<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03183349</url>
  </required_header>
  <id_info>
    <org_study_id>cebc.Cairouni</org_study_id>
    <nct_id>NCT03183349</nct_id>
  </id_info>
  <brief_title>Immediate Implant Placement With Platlet Rich Fibrin as Space Filling Material Versus the Use of Deprotienized Bovine Bone (Tutogen) in Maxillary Premolars.</brief_title>
  <official_title>Immediate Implant Placement With Platlet Rich Fibrin as Space Filling Material Versus the Use of Deprotienized Bovine Bone (Tutogen) in Maxillary Premolars. A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      20 subjects suffering from non restorable maxillary premolar teeth will be randomly devided
      into two groups. the selected teeth will be extracted and immeiate implants will be placed in
      all subjects. the first group will recieve deprotienized bovine bone (tutogen) to fill the
      buccal space between the implant and the bone, the second group will recieve platlet rich
      fibrin to fill the buccal space between the implant and the bone
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient morbidity</measure>
    <time_frame>14 days</time_frame>
    <description>patient pain level on pain scale using pain chart</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>crestal bone loss</measure>
    <time_frame>3 months</time_frame>
    <description>radiographic analysis computing amount of crestal bone loss around implants using cone beam computed tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>implants stability quotient</measure>
    <time_frame>3 months</time_frame>
    <description>implant stability measured using resonance frequency analysis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Immediate Dental Implant</condition>
  <arm_group>
    <arm_group_label>platelet rich fibrin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>immediate implant grafting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>deprotienized bovine bone (tutogen)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>immediate implant grafting</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>deprotienized bovine bone (tutogen)</intervention_name>
    <arm_group_label>platelet rich fibrin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>platelet rich fibrin</intervention_name>
    <arm_group_label>deprotienized bovine bone (tutogen)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  non restorable maxillary premolars non smoker free from any systemic disease or
             medication that could impair normal bone healing

        Exclusion Criteria:

          -  any systemic disease that could affect bone healing patient with lesion related to the
             surgical site
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2017</study_first_submitted>
  <study_first_submitted_qc>June 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2017</study_first_posted>
  <last_update_submitted>June 10, 2017</last_update_submitted>
  <last_update_submitted_qc>June 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ahmed mohamed awad elbrashy</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

